Profund Advisors LLC United Therapeutics Corp Transaction History

Profund Advisors LLC

  • $2.59 Billion
  • Q3 2024

A detailed history of Profund Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Profund Advisors LLC holds 10,642 shares of UTHR stock, worth $3.83 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,642
Previous 12,638 15.79%
Holding current value
$3.83 Million
Previous $4.03 Million 5.27%
% of portfolio
0.15%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$311.04 - $363.55 $620,835 - $725,645
-1,996 Reduced 15.79%
10,642 $3.81 Million
Q2 2024

Aug 13, 2024
BUY
$228.26 - $319.04 $1.22 Million - $1.7 Million
5,338 Added 73.12%
12,638 $4.03 Million
Q1 2024

May 08, 2024
BUY
$210.76 - $249.51 $7,376 - $8,732
35 Added 0.48%
7,300 $1.68 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $105,935 - $126,671
-493 Reduced 6.35%
7,265 $1.6 Million
Q3 2023

Nov 13, 2023
SELL
$211.82 - $248.24 $35,585 - $41,704
-168 Reduced 2.12%
7,758 $1.75 Million
Q2 2023

Aug 10, 2023
BUY
$205.19 - $232.99 $196,777 - $223,437
959 Added 13.76%
7,926 $1.75 Million
Q1 2023

May 11, 2023
BUY
$212.99 - $276.17 $81,575 - $105,773
383 Added 5.82%
6,967 $1.56 Million
Q4 2022

Feb 02, 2023
BUY
$205.95 - $280.43 $9,267 - $12,619
45 Added 0.69%
6,584 $1.83 Million
Q3 2022

Nov 04, 2022
SELL
$203.3 - $244.17 $69,731 - $83,750
-343 Reduced 4.98%
6,539 $1.37 Million
Q2 2022

Aug 01, 2022
SELL
$174.81 - $241.14 $167,817 - $231,494
-960 Reduced 12.24%
6,882 $1.62 Million
Q1 2022

May 10, 2022
SELL
$166.16 - $213.96 $56,826 - $73,174
-342 Reduced 4.18%
7,842 $1.41 Million
Q4 2021

Feb 08, 2022
SELL
$184.32 - $216.08 $214,364 - $251,301
-1,163 Reduced 12.44%
8,184 $1.77 Million
Q3 2021

Nov 12, 2021
SELL
$179.86 - $214.88 $133,995 - $160,085
-745 Reduced 7.38%
9,347 $1.73 Million
Q2 2021

Aug 12, 2021
SELL
$170.47 - $211.93 $25,059 - $31,153
-147 Reduced 1.44%
10,092 $1.81 Million
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $178,262 - $202,476
-1,158 Reduced 10.16%
10,239 $1.71 Million
Q4 2020

Feb 09, 2021
BUY
$101.87 - $151.79 $155,453 - $231,631
1,526 Added 15.46%
11,397 $1.73 Million
Q3 2020

Nov 13, 2020
SELL
$99.9 - $121.13 $156,843 - $190,174
-1,570 Reduced 13.72%
9,871 $997,000
Q2 2020

Aug 03, 2020
BUY
$92.74 - $125.82 $162,109 - $219,933
1,748 Added 18.03%
11,441 $1.38 Million
Q1 2020

May 15, 2020
SELL
$79.39 - $115.35 $340,027 - $494,044
-4,283 Reduced 30.65%
9,693 $919,000
Q4 2019

Feb 18, 2020
BUY
$78.31 - $95.34 $70,479 - $85,806
900 Added 6.88%
13,976 $1.23 Million
Q3 2019

Nov 12, 2019
SELL
$74.85 - $85.99 $54,415 - $62,514
-727 Reduced 5.27%
13,076 $1.04 Million
Q2 2019

Aug 13, 2019
SELL
$76.06 - $120.81 $145,350 - $230,867
-1,911 Reduced 12.16%
13,803 $1.08 Million
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $137,259 - $162,482
1,281 Added 8.88%
15,714 $1.84 Million
Q4 2018

Feb 14, 2019
SELL
$101.4 - $128.73 $498,888 - $633,351
-4,920 Reduced 25.42%
14,433 $1.57 Million
Q3 2018

Nov 13, 2018
BUY
$113.81 - $129.46 $91,617 - $104,215
805 Added 4.34%
19,353 $2.48 Million
Q2 2018

Aug 13, 2018
SELL
$101.14 - $118.31 $98,611 - $115,352
-975 Reduced 4.99%
18,548 $2.1 Million
Q1 2018

May 14, 2018
SELL
$107.21 - $151.94 $102,599 - $145,406
-957 Reduced 4.67%
19,523 $2.19 Million
Q4 2017

Feb 14, 2018
SELL
$118.58 - $151.28 $246,883 - $314,964
-2,082 Reduced 9.23%
20,480 $3.03 Million
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $113,683 - $135,715
992 Added 4.6%
22,562 $2.64 Million
Q2 2017

Aug 11, 2017
BUY
N/A
21,570
21,570 $2.8 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email